NEURONASCENT INC
Neural interface system for recording and decoding brain signals to restore motor function in paralyzed patients
- Sector
- Medtech
- Headquarters
- CLARKSVILLE, MD
- Latest Form D
- $1.2M, Mar 2015
- Total capital
- $1.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.2M
- 1 Form D · last Mar 2015
- 139 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 8 pending · first 2015
- Rank in peer group#370 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$1.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#370 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Judith Kelleher-AnderssonResearcherExecutive Officer, DirectorLinked by 3 patents
- Kathleen MattisExecutive Officer, DirectorNamed in SEC Form D filings
- Maurice GagnonDirectorNamed in SEC Form D filings
- Robin OegerleDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 11- PendingMethods And Compositions For Lipid Formulation Of Lipophilic Small Molecule Therapies Of The Heterocyclic TypeUSPTOApplication 18568686
- GrantedMethods and Compositions For Stimulating Neurogenesis And Inhibiting Neuronal Degeneration Using IsothiazolopyrimidinonesUSPTOUS 9,592,234
- GrantedMethods and Compositions For Stimulating Neurogenesis and Inhibiting Neuronal DegenerationUSPTOUS 9,539,261
Show all 11 patent records
- Methods And Compositions For Lipid Formulation Of Lipophilic Small Molecule Therapies Of The Heterocyclic TypeAug 29, 2024 · Application 18568686Pending
- Methods and Compositions For Stimulating Neurogenesis And Inhibiting Neuronal Degeneration Using IsothiazolopyrimidinonesMar 14, 2017 · US 9,592,234Granted
- Methods and Compositions For Stimulating Neurogenesis and Inhibiting Neuronal DegenerationJan 10, 2017 · US 9,539,261Granted
- Methods and Pharmaceutical Compositions For Treating Down SyndromeSep 10, 2015 · Application 14613601Pending
- Methods And Compositions For Stimulating Neurogenesis And Inhibiting Neuronal Degeneration Using IsothiazolopyrimidinonesAug 4, 2015 · US 9,096,613Granted
- Methods And Compositions For Lipid Formulation Of Lipophilic Small Molecule Therapies Of The Heterocyclic TypeApplication PCTUS2022032955Pending
- Methods And Compositions For Stimulating Neurogenesis And Inhibiting Neuronal Degeneration Using IsothiazolopyrimidinonesApplication PCTUS2008067742Pending
- Isolation And Differentiation Of Adult Hippocampal Arctic Ground Squirrel Neural Stem CellsApplication PCTUS2007077355Pending
- Methods And Compositions For Lipid Formulation Of Lipophilic Small Molecule Therapies Of The Heterocyclic TypeApplication 63209841Pending
- Methods And Compositions For Stimulating Neurogenesis And Inhibiting Neuronal DegenerationApplication PCTUS2006036463Pending
- Methods And Compositions For Lipid Formulation Of Lipophilic Small Molecule Therapies Of The Heterocyclic TypeApplication 63340230Pending
Related companies, and why
- Gaize, Inc.Similar federal contract value in Medtech · null in contracts
- BROOKLYN INNOSEQ INC.Similar federal contract value in Medtech · null in contracts
- VIRTUOSO SURGICAL, INC.Similar federal contract value in Medtech · null in contracts
- OSTIAL SOLUTIONS LLCSimilar federal contract value in Medtech · null in contracts
- CAREBAND, INC.Similar federal contract value in Medtech · null in contracts
- OXYBAND TECHNOLOGIES INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .